Hematologic Malignancy
Myeloid Neoplasm Post Cytotoxic Therapy
CI-CAN-00001253Explore in graph →
Hematologic20 active trials
Loading cancer entity…
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00001253Explore in graph →
Provenance
Every source that supplied a code, alias, edge, observation or derived value, with the ingest runs involved.
| Source | License | Contributions | Ingest runs | Last retrieved |
|---|---|---|---|---|
| NCI Thesaurus (NCIt) ncit-evs | approved | Aliases, Codes, Description, Hierarchy, Source Records | ING-NCITEVS-20260908-000001 | Sep 8, 2026, 09:44 AM UTC |
| OncoTree oncotree | approved | Codes, Hierarchy | — | — |
| PubMed (NCBI E-utilities) pubmed | approved | Literature Counts | ING-PUBMED-20260928-000001 | Sep 28, 2026, 03:00 AM UTC |
Identifiers
Every upstream identifier is kept with its match type; nothing is buried in JSON.
Names
| Alias | Type | Terminology | Language |
|---|---|---|---|
| Myeloid Neoplasm Post Cytotoxic Therapy | preferred | NCIt | en |
| Acute Myeloid Leukaemias and Myelodysplastic Syndromes, Therapy-Related | synonym | NCIt | en |
| Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome | synonym | NCIt | en |
| Therapy-Related AML and MDS | synonym | NCIt | en |
| Therapy related myeloid neoplasm | synonym | NCIt | en |
Change history
Creation, updates, merges and ranking changes recorded for this entity.